HilleVax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	91	777	558	-	-
Market Cap Growth	27.39%	39.35%	-	-	-
Enterprise Value	-135	523	313	34	3
PE Ratio	-	-6.29	-3.49	-	-
PB Ratio	0.37	2.93	2.09	-	-
P/FCF Ratio	-7.40	-7.97	-8.45	-	-
P/OCF Ratio	-7.96	-8.96	-9.00	-	-
EV/EBITDA Ratio	-4.36	-4.40	-2.02	-0.34	-1.24
EV/EBIT Ratio	-4.28	-4.32	-2.00	-0.34	-1.24
EV/FCF Ratio	-5.40	-5.37	-4.75	-4.62	-2.02
Debt / Equity Ratio	0.21	0.19	0.14	-1.57	-1.09
Debt / EBITDA Ratio	-0.37	-0.43	-0.23	-1.59	-1.46
Debt / FCF Ratio	-0.46	-0.52	-0.55	-21.59	-2.38
Quick Ratio	10.66	10.43	21.54	0.55	0.14
Current Ratio	10.92	10.62	22.28	0.55	0.15
Interest Coverage	-52.75	-50.66	-45.81	-35.01	-71.52
Return on Equity (ROE)	-56.20%	-48.20%	-92.70%	197.80%	-
Return on Assets (ROA)	-43.70%	-38.10%	-58.40%	-160.40%	-
Return on Capital (ROIC)	-53.13%	-42.10%	-21.45%	-92.59%	-515.94%
Earnings Yield	-163.06%	-15.89%	-28.65%	-	-
FCF Yield	-126.98%	-12.55%	-11.83%	-	-
Buyback Yield / Dilution	-28.36%	-49.55%	-383.12%	-28.65%	-
Total Shareholder Return	-28.36%	-49.55%	-383.12%	-28.65%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).